Predictive Oncology
POAI
POAI
11 hedge funds and large institutions have $267K invested in Predictive Oncology in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$51K |
2 |
2
Barclays
London,
United Kingdom
|
$44K |
3 |
3
Northern Trust
Chicago,
Illinois
|
$20K |
Top Sellers
1 |
VF
1
Virtu Financial
New York
|
$16K |
2 |
TSS
2
Two Sigma Securities
New York
|
$0 |
3 |
3
UBS Group
Zurich,
Switzerland
|
$0 |
4 |
4
Citadel Advisors
Miami,
Florida
|
$21K |